Mashup Score: 1
New England Journal of Medicine (NEJM)Original Article from The New England Journal of Medicine — Darolutamide and Survival in Metastatic, Hormone-Sensitive Prostate Cancer
See more from Catherine Marshall
The newest entry into the metastatic hormone sensitive prostate cancer space….for those who were going to get docatexel (high volume disease), seems reasonable to add darolutamide now.